Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: J Comp Neurol. 2015 Jun 10;523(16):2426–2456. doi: 10.1002/cne.23797

Table 1. Table of primary antibodies used.

List of the primary antibodies used in the study with their respective specifications.

Antigen Description of immunogen Source, host species, cat. #, clone or lot #, RRID Working concentration used (µg/ml)
calbindin purified bovine kidney CB 28 kD Sigma Chemical Co., cat. # C9848, RRID: AB_476894 8.3
cholera toxin β subunit Ctβ itself List Biological Laboratories, cat. #703, RRID: AB_10013220 15.3
Fluorogold FG itself Millipore, cat. #AB153, RRID: AB_90738 30.5
Fos synthetic peptide corresponding to amino acids 4-17 (SGFNADYEASSSRC) of human c-Fos Calbiochem, cat. # PC38, RRID: AB_2313765 11.5
nitric oxide synthase amino acids 251-270 of nitric oxide synthase (GDNDRVFNDLWGKDNVPVILC) conjugated to keyhole limpet cyanin Sigma Chemical Company, cat. #N7155, RRID: AB_260795 21.5
μ-opioid receptor synthetic peptide corresonding to amino acids LENLEAETAPLP at the COOH terminus of the μ-opioid receptor Gramsch Laboratories, cat. # OR-600, RRID: AB_2314811 16.0
parvalbumin purified carp muscle parvalbumin Sigma Chemical Co., clone PA-235, cat. # P3088, RRID: AB 477329 26.3
tyrosine hydroxylase tyrosine hydroxylase from PC12 cells Millipore, cat. # MAB318, RRID: AB_2315522 28.8